These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 29671795)

  • 1. 4-Hydroxypiperidines and Their Flexible 3-(Amino)propyloxy Analogues as Non-Imidazole Histamine H₃ Receptor Antagonist: Further Structure⁻Activity Relationship Exploration and In Vitro and In Vivo Pharmacological Evaluation.
    Olszewska B; Stasiak A; McNaught Flores D; Fogel WA; Leurs R; Walczyński K
    Int J Mol Sci; 2018 Apr; 19(4):. PubMed ID: 29671795
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-Imidazole Histamine H₃ Ligands. Part VII. Synthesis, In Vitro and In Vivo Characterization of 5-Substituted-2-thiazol-4-n-propylpiperazines.
    Guryn R; Staszewski M; Stasiak A; McNaught Flores D; Fogel WA; Leurs R; Walczyński K
    Molecules; 2018 Feb; 23(2):. PubMed ID: 29401659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure-activity relationships of new 1-substitutedmethyl-4-[5-(N-methyl-N-propylamino)pentyloxy]piperidines and selected 1-[(N-substituted-N-methyl)-3-propyloxy]-5-(N-methy-l-N-propyl)-pentanediamines as H3 -antagonists.
    Masłowska-Lipowicz I; Walczyński K
    Chem Biol Drug Des; 2014 Jan; 83(1):106-18. PubMed ID: 23957330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New 1-benzyl-4-hydroxypiperidine derivatives as non-imidazole histamine H3 receptor antagonists.
    Maslowska-Lipowicz I; Figlus M; Zuiderveld OP; Walczynski K
    Arch Pharm (Weinheim); 2008 Dec; 341(12):762-73. PubMed ID: 19009544
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-Imidazole Histamine H3 Ligands. Part VI. Synthesis and Preliminary Pharmacological Investigation of Thiazole-Type Histamine H3-Receptor Antagonists with Lacking a Nitrogen Nucleus in the Side Chain.
    Guryn R; Staszewski M; Kopczacki P; Walczyski K
    Med Chem; 2016; 13(1):65-76. PubMed ID: 27220560
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and preliminary pharmacological investigation of new N-substituted-N-[ω-(ω-phenoxy-alkylpiperazin-1-yl)alkyl]guanidines as non-imidazole histamine H(3) antagonists.
    Staszewski M; Walczyński K
    Arch Pharm (Weinheim); 2012 Jun; 345(6):431-43. PubMed ID: 22415744
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-imidazole histamine H3 ligands, part IV: SAR of 1-[2-thiazol-5-yl-(2-aminoethyl)]-4-n-propylpiperazine derivatives.
    Frymarkiewicz A; Walczyński K
    Eur J Med Chem; 2009 Apr; 44(4):1674-81. PubMed ID: 18990469
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo receptor occupancy assay of histamine H₃ receptor antagonist in rats using non-radiolabeled tracer.
    Nirogi R; Kandikere V; Bhyrapuneni G; Muddana N; Saralaya R; Ponnamaneni RK; Manoharan AK
    J Pharmacol Toxicol Methods; 2012; 65(3):115-21. PubMed ID: 22487318
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery of histamine H3 receptor antagonistic property of simple imidazole-free derivatives: Preliminary pharmacological investigation.
    Barocelli E; Ballabeni V; Manenti V; Flammini L; Bertoni S; Morini G; Comini M; Impicciatore M
    Pharmacol Res; 2006 Mar; 53(3):226-32. PubMed ID: 16364652
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anticonvulsant effects of isomeric nonimidazole histamine H
    Sadek B; Saad A; Schwed JS; Weizel L; Walter M; Stark H
    Drug Des Devel Ther; 2016; 10():3633-3651. PubMed ID: 27853355
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anticonvulsant and procognitive properties of the non-imidazole histamine H3 receptor antagonist DL77 in male adult rats.
    Sadek B; Saad A; Subramanian D; Shafiullah M; Łażewska D; Kieć-Kononowiczc K
    Neuropharmacology; 2016 Jul; 106():46-55. PubMed ID: 26525191
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dual-acting drugs: an in vitro study of nonimidazole histamine H3 receptor antagonists combining anticholinesterase activity.
    Incerti M; Flammini L; Saccani F; Morini G; Comini M; Coruzzi M; Barocelli E; Ballabeni V; Bertoni S
    ChemMedChem; 2010 Jul; 5(7):1143-9. PubMed ID: 20512794
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-imidazole histamine H3 receptor ligands incorporating antiepileptic moieties.
    Sadek B; Schwed JS; Subramanian D; Weizel L; Walter M; Adem A; Stark H
    Eur J Med Chem; 2014 Apr; 77():269-79. PubMed ID: 24650714
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel naphthyloxy derivatives - Potent histamine H
    Łażewska D; Kaleta M; Hagenow S; Mogilski S; Latacz G; Karcz T; Lubelska A; Honkisz E; Handzlik J; Reiner D; Satała G; Filipek B; Stark H; Kieć-Kononowicz K
    Bioorg Med Chem; 2018 May; 26(9):2573-2585. PubMed ID: 29681486
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery of novel steroidal histamine H
    Ledneczki I; Tapolcsányi P; Gábor E; Éles J; Greiner I; Schmidt É; Némethy Z; Kedves RS; Balázs O; Román V; Lévay G; Mahó S
    Bioorg Med Chem Lett; 2017 Oct; 27(19):4525-4530. PubMed ID: 28888822
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel nonimidazole histamine H3 receptor antagonists: 1-(4-(phenoxymethyl)benzyl)piperidines and related compounds.
    Mikó T; Ligneau X; Pertz HH; Ganellin CR; Arrang JM; Schwartz JC; Schunack W; Stark H
    J Med Chem; 2003 Apr; 46(8):1523-30. PubMed ID: 12672253
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural modifications in the distal, regulatory region of histamine H
    Szczepańska K; Pockes S; Podlewska S; Höring C; Mika K; Latacz G; Bednarski M; Siwek A; Karcz T; Nagl M; Bresinsky M; Mönnich D; Seibel U; Kuder KJ; Kotańska M; Stark H; Elz S; Kieć-Kononowicz K
    Eur J Med Chem; 2021 Mar; 213():113041. PubMed ID: 33261900
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro characterization of potency, affinity and selectivity of H3-antagonists: from thioperamide to thioperamide unrelated imidazole derivatives.
    Barocelli E; Ballabeni V; Caretta A; Bertoni S; Bordi F; Rivara S; Silva C; Mor M; Impicciatore M
    Farmaco; 1997; 52(6-7):463-9. PubMed ID: 9372599
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological and behavioral properties of A-349821, a selective and potent human histamine H3 receptor antagonist.
    Esbenshade TA; Fox GB; Krueger KM; Baranowski JL; Miller TR; Kang CH; Denny LI; Witte DG; Yao BB; Pan JB; Faghih R; Bennani YL; Williams M; Hancock AA
    Biochem Pharmacol; 2004 Sep; 68(5):933-45. PubMed ID: 15294456
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural variations of 1-(4-(phenoxymethyl)benzyl)piperidines as nonimidazole histamine H3 receptor antagonists.
    Mikó T; Ligneau X; Pertz HH; Arrang JM; Ganellin CR; Schwartz JC; Schunack W; Stark H
    Bioorg Med Chem; 2004 May; 12(10):2727-36. PubMed ID: 15110854
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.